Travere Therapeutics, Inc. TVTX Other Working Capital
Other Working Capital at other companies
Other financials
Where this comes from
Reported directly by Travere Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherNoncashIncomeExpense.
The official record: Travere Therapeutics, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Travere Therapeutics, Inc.'s other working capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Travere Therapeutics, Inc.'s other working capital?
- Travere Therapeutics, Inc. (TVTX) reported other working capital of $4K in Q1 2026.
- How has Travere Therapeutics, Inc.'s other working capital changed year-over-year?
- Travere Therapeutics, Inc.'s other working capital decreased by 99.7% year-over-year, from $1.57M to $4K.
- What does other working capital mean?
- Net change in working capital items not separately classified — a residual balancing item.